SUN-303 Effects of Open-Label, Adjunctive Ganaxalone Treatment on Resistant Depression in Postmenopausal Women: A Pilot Study

Resistance to selective serotonin reuptake inhibitor and serotonin norepinephrine reuptake inhibitor treatment occurs in about 50% to 70% of patients with major depressive disorder (MDD), a condition associated with significant morbidity that affects women at higher rates than men. Few well-tolerate...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Endocr Soc
Autors principals: Dichtel, Laura E, Nyer, Maren, Dording, Christina, Fisher, Lauren B, Cusin, Christin, Shapero, Benjamin G, Pedrelli, Paola, Kimball, Allison, Rao, Elizabeth M, Mischoulon, David, Fava, Maurizio, Miller, Karen Klahr
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Neuroendocrinology and Pituitary
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7207288/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.082
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars